Eli Lilly and Co (XSWX:LLY) Dividend Payout Ratio: 0.20 (As of Mar. 2026) — 55% Below Median


XSWX:LLY Eli Lilly and Co XSWX:LLY
100 GF Score
Price CHF955.00
GF Value CHF1,111.74
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Eli Lilly and Co Dividend Payout Ratio?

Eli Lilly and Co XSWX:LLY 100 Dividend Payout Ratio is 0.20 as of Mar. 2026, which is 55% below its 10-year median of 0.44. GuruFocus rates XSWX:LLY with a GF Score™ of 100/100 and a GF Value™ of CHF1,111.74 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 444 Drug Manufacturers companies, Eli Lilly and Co ranks better than 74.77% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Eli Lilly and Co's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.20.

The historical rank and industry rank for Eli Lilly and Co's Dividend Payout Ratio or its related term are showing as below:

XSWX:LLY' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.21   Med: 0.44   Max: 0.72
Current: 0.21

During the past 13 years, the highest Dividend Payout Ratio of Eli Lilly and Co was 0.72. The lowest was 0.21. And the median was 0.44.

XSWX:LLY's Dividend Payout Ratio is ranked better than
74.77% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.375 vs XSWX:LLY: 0.21

As of today (2026-06-27), the Dividend Yield % of Eli Lilly and Co is 0.57%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Eli Lilly and Co was 3.00%. The lowest was 0.51%. And the median was 1.41%.

Eli Lilly and Co's Dividends per Share for the months ended in Mar. 2026 was CHF1.36.

During the past 12 months, Eli Lilly and Co's average Dividends Per Share Growth Rate was 15.40% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 15.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 15.20% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 12.50% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Eli Lilly and Co was 20.20% per year. The lowest was 0.00% per year. And the median was 7.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Eli Lilly and Co (XSWX:LLY) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Eli Lilly and Co Dividend Payout Ratio Related Terms

Eli Lilly and Co Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co Dividend Payout Ratio Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.42 0.49 0.72 0.40 0.25

Eli Lilly and Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.24 0.21 0.20 0.20

XSWX:LLY vs JNJ, ABBV, MRK: Dividend Payout Ratio Comparison

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eli Lilly and Co Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Dividend Payout Ratio falls into.


XSWX:LLY
100GF Score
Eli Lilly and Co XSWX:LLY
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eli Lilly and Co Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Eli Lilly and Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=4.781/ 19.293
=0.25

Eli Lilly and Co's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=1.362/ 6.731
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.20 mean?
Eli Lilly and Co (XSWX:LLY) has a Dividend Payout Ratio of 0.20 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Eli Lilly and Co and its competitors. This is 55% below median its historical median of 0.44. Over the past decade, Eli Lilly and Co's Dividend Payout Ratio has ranged from 0.21 to 0.72. According to the industry distribution chart, Eli Lilly and Co ranks #112 out of 444 companies in the Drug Manufacturers industry, placing it in the top 25.2%.
Is Eli Lilly and Co's Dividend Payout Ratio too high?
Eli Lilly and Co's current Dividend Payout Ratio of 0.20 is 55% below median its 10-year median of 0.44. Over the past 10 years, this metric has ranged from a low of 0.21 to a high of 0.72. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Eli Lilly and Co's value of 0.20 is 46.7% below this industry median. Based on the distribution chart, Eli Lilly and Co ranks #112 out of 444 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Eli Lilly and Co has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eli Lilly and Co's Dividend Payout Ratio compare to JNJ and ABBV?
According to the Drug Manufacturers industry distribution chart, Eli Lilly and Co ranks #112 out of 444 companies for Dividend Payout Ratio. This puts Eli Lilly and Co in the upper half of its industry. The industry median Dividend Payout Ratio is 0.38. Eli Lilly and Co's value of 0.20 is 46.7% below this benchmark. Historically, Eli Lilly and Co's own Dividend Payout Ratio has ranged from 0.21 to 0.72 over the past decade. While the company's 10-year median is 0.44 vs. the industry median of 0.38, Eli Lilly and Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eli Lilly and Co's current Dividend Payout Ratio of 0.20 is 46.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Eli Lilly and Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eli Lilly and Co's current Dividend Payout Ratio is 0.20, which is 55% below median its own 10-year median of 0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eli Lilly and Co stock overvalued right now?
Based on GuruFocus' analysis, Eli Lilly and Co (XSWX:LLY) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF1,111.74, compared to a current price of CHF955.00 — trading 14.1% below its estimated fair value. The current Dividend Payout Ratio is 0.20, which is 55% below median its 10-year median of 0.44 and 46.7% below the Drug Manufacturers industry median of 0.38. Eli Lilly and Co's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Eli Lilly and Co (XSWX:LLY), the current Dividend Payout Ratio is 0.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eli Lilly and Co (XSWX:LLY) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of CHF955.00 is trading 14.1% below its estimated GF Value™ of CHF1,111.74. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for XSWX:LLY:

  • Dividend Payout Ratio: 0.20 (55% below median its 10-year median of 0.44)
  • GF Value™: CHF1,111.74 vs. price of CHF955.00 (14.1% below fair value)
  • GF Score™: 100/100 with 5 warning signs
  • Industry Position: 46.7% below the Drug Manufacturers median (#112 of 444)

No single metric tells the full story. See the XSWX:LLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
100GF Score

Get the complete analysis for XSWX:LLY

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF955.00
Price
CHF1,111.74
GF Value